Articles by Michelle Hoffman - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Michelle Hoffman

Headed Up or Down? Pharma's Position in the Current Economy

Results from our annual employment survey.
Dec 2, 2009

Results from our annual employment survey.

DIY Healthcare Reform

While Congress debates hundreds of healthcare plan proposals, perhaps we, the public, can get in the game too.
Nov 2, 2009

While Congress debates hundreds of healthcare plan proposals, perhaps we, the public, can get in the game too.

Targeting Therapeutics for the Middle and Inner Ear

A Conversation with Otonomy
Nov 1, 2009

A Conversation with Otonomy

Technology Forecast for Injectables

A Conversation with Greystone Associates' George Perros. This article contains bonus online-exclusive material.
Nov 1, 2009

A Conversation with Greystone Associates' George Perros. This article contains bonus online-exclusive material.

Quality by Enforcement

After years of promomting QbD concepts, FDA's ready to take action on nonconformers.
Sep 2, 2009

After years of promomting QbD concepts, FDA's ready to take action on nonconformers.

The Pharma Family Tree

View the corporate lineages of pharma's top companies.
Aug 2, 2009

View the corporate lineages of pharma's top companies.

Of Hubris and Happy Endings

Individuals and companies at the top seem to have no problem short-circuiting their success.
Aug 2, 2009

Individuals and companies at the top seem to have no problem short-circuiting their success.

Growing Pains

As the pharmaceutical supply chain expands, sponsor companies need to weigh all their options.
Aug 1, 2009

As the pharmaceutical supply chain expands, sponsor companies need to weigh all their options.

The Good Society

Is it good policy to pay for bad behavior?
Jul 2, 2009

Is it good policy to pay for bad behavior?

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here